文献速递类风湿关节炎

类风湿关节炎中微生物失调与代谢紊乱的阶段特异性作用

Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2022-11-10

本研究对76例按2010年RA分类标准分为I–IV期的类风湿关节炎患者、19例骨关节炎患者和27名健康人进行粪便宏基因组和血浆代谢组分析,并在271例四期RA验证队列中通过16S rRNA基因测序、细菌分离和扫描电镜验证细菌侵入关节滑液。结果显示微生物失调与代谢紊乱在不同RA阶段呈现不同模式并发挥阶段特异性作用。

要点

  • 拟杆菌属均匀拟杆菌(Bacteroides uniformis)和肋拟杆菌(Bacteroides plebeius)耗竭削弱糖胺聚糖代谢(p<0.001),持续损伤关节软骨。
  • 大肠杆菌(Escherichia coli)升高增强II期和III期精氨酸琥珀酰转移酶途径(p<0.001),与类风湿因子升高相关(p=1.35×10-3)。
  • 甲氧基乙酸(p=1.28×10-8)和半胱氨酸-S-硫酸盐(p=4.66×10-12)分别抑制II期成骨细胞和增强III期破骨细胞;IV期肠道通透性持续增加可能诱导肠道微生物侵入关节滑液。

核心结论

  • 临床微生物干预应考虑RA分期,微生物失调和代谢紊乱在不同阶段呈现不同模式并发挥阶段特异性作用。
  • 本研究从分期角度为理解肠-关节轴提供了新见解,为RA预后和治疗开辟了新途径。

研究设计与样本

  • 研究纳入76例按2010年RA分类标准分为I–IV期的RA患者、19例骨关节炎患者和27名健康人,分析粪便宏基因组和血浆代谢组。
  • 另在271例四期RA验证队列中采用16S rRNA基因测序、细菌分离和扫描电子显微镜验证细菌侵入关节滑液。

主要发现

  • 拟杆菌属均匀拟杆菌和肋拟杆菌耗竭削弱糖胺聚糖代谢(p<0.001),持续损伤四个阶段的关节软骨。
  • 大肠杆菌升高增强II期和III期精氨酸琥珀酰转移酶途径(p<0.001),与类风湿因子升高相关(p=1.35×10-3),并可诱导骨丢失。
  • 甲氧基乙酸水平异常升高(p=1.28×10-8)在II期抑制成骨细胞,半胱氨酸-S-硫酸盐水平异常升高(p=4.66×10-12)在III期增强破骨细胞,分别促进骨侵蚀。
  • 肠道通透性持续增加可能诱导IV期肠道微生物侵入关节滑液。

关键数值与推荐

  • RA按2010年RA分类标准分为I–IV期。
  • 拟杆菌属均匀拟杆菌和肋拟杆菌耗竭削弱糖胺聚糖代谢,p<0.001。
  • 大肠杆菌增强II期和III期精氨酸琥珀酰转移酶途径,p<0.001,与类风湿因子升高相关,p=1.35×10-3。
  • 甲氧基乙酸抑制II期成骨细胞,p=1.28×10-8;半胱氨酸-S-硫酸盐增强III期破骨细胞,p=4.66×10-12。

临床怎么用

  • 作者认为临床微生物干预应考虑RA分期。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Rheumatoid arthritis (RA) is a progressive disease including four stages, where gut microbiome is associated with pathogenesis. We aimed to investigate stage-specific roles of microbial dysbiosis and metabolic disorders in RA. METHODS: We investigated stage-based profiles of faecal metagenome and plasma metabolome of 76 individuals with RA grouped into four stages (stages I-IV) according to 2010 RA classification criteria, 19 individuals with osteroarthritis and 27 healthy individuals. To verify bacterial invasion of joint synovial fluid, 16S rRNA gene sequencing, bacterial isolation and scanning electron microscopy were conducted on another validation cohort of 271 patients from four RA stages. RESULTS: First, depletion of Bacteroides uniformis and Bacteroides plebeius weakened glycosaminoglycan metabolism (p<0.001), continuously hurting articular cartilage across four stages. Second, elevation of Escherichia coli enhanced arginine succinyltransferase pathway in the stage II and stage III (p<0.001), which was correlated with the increase of the rheumatoid factor (p=1.35×10-3) and could induce bone loss. Third, abnormally high levels of methoxyacetic acid (p=1.28×10-8) and cysteine-S-sulfate (p=4.66×10-12) inhibited osteoblasts in the stage II and enhanced osteoclasts in the stage III, respectively, promoting bone erosion. Fourth, continuous increase of gut permeability may induce gut microbial invasion of the joint synovial fluid in the stage IV. CONCLUSIONS: Clinical microbial intervention should consider the RA stage, where microbial dysbiosis and metabolic disorders present distinct patterns and played stage-specific roles. Our work provides a new insight in understanding gut-joint axis from a perspective of stages, which opens up new avenues for RA prognosis and therapy.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Cheng M, Zhao Y, Cui Y, et al. Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis. Ann Rheum Dis. 2022. PMID: 35985811. doi:10.1136/ard-2022-222871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。